Key Insights

Highlights

Success Rate

62% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 77/100

Termination Rate

26.3%

5 terminated out of 19 trials

Success Rate

61.5%

-25.0% vs benchmark

Late-Stage Pipeline

11%

2 trials in Phase 3/4

Results Transparency

25%

2 of 8 completed with results

Key Signals

2 with results62% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (3)
P 1 (1)
P 2 (7)
P 3 (1)
P 4 (1)

Trial Status

Completed8
Terminated5
Unknown3
Withdrawn2
Recruiting1

Trial Success Rate

61.5%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT05077332Phase 2Completed

LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)

NCT04790240Phase 1RecruitingPrimary

Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)

NCT05077969Phase 2Terminated

Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients

NCT05268679Completed

Covid-19 Vaccine Response in Heart Transplant Recipients

NCT04778059Phase 2Terminated

Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19

NCT05085574Phase 2Withdrawn

Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)

NCT05489367CompletedPrimary

Does COVİD-19 m-RNA Vaccine Affect Fertility and Over Reserve ?

NCT05208983UnknownPrimary

SafeTy and Efficacy of Preventative CoVID Vaccines

NCT05514691Not ApplicableCompletedPrimary

Evaluation of Clinical Performance and Usability of iStatis COVID-19 Ag Rapid Test at POC

NCT05364268Completed

Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation

NCT05446961Phase 2CompletedPrimary

Clinical Study to Evaluate the Effect of Food Supplement in People Infected With Coronavirus

NCT05371561Not ApplicableCompleted

Effect of PPE on Children's Fear in Dental Office

NCT04847583Phase 2TerminatedPrimary

A Phase 2 Study to Evaluate Biomarker Change, Efficacy, Pharmacokinetics, Safety and Tolerability of Telacebec (Q203) in Covid-19 Patients

NCT04560881Phase 3CompletedPrimary

Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)

NCT05133635Phase 4WithdrawnPrimary

High-Dose Corticosteroid or Tocilizumab for Clinical Worsening of COVID-19

NCT04786808TerminatedPrimary

Risk Factors for COVID-19 Mortality

NCT05087225Unknown

Suspicion of Hypoglycemic Effect of mRNA Based Covid-19 Vaccines (Polyethylene Glycol) Will Happen , Observational Study on Diabetic Patients at Saudia Arabia

NCT04964154Not ApplicableUnknownPrimary

Building Resiliency and Vital Equity (BRAVE) Project: Understanding Native Americans' Perceptions/Beliefs About COVID-19 Testing and Vaccination Study

NCT04449380Phase 2TerminatedPrimary

Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients

Showing all 19 trials

Research Network

Activity Timeline